Movi Health

What Movi Health does

Movi Health (ТОВ "Мові Хелс") is a privately held Ukrainian pharmaceutical company founded in 2008 and headquartered in Kyiv. It develops, manufactures, and markets a portfolio of prescription and over-the-counter (OTC) medications organized around three therapeutic verticals: joint and musculoskeletal health (the Movex line of chondroprotectors combining glucosamine sulfate and chondroitin sulfate, the orodispersible meloxicam tablet Movixicam ODT, and MoviFlex DEX for acute pain); respiratory conditions (PulmoBREEZE and PulmoLOR for upper respiratory tract, throat and ENT indications, plus the Movinaza nasal product); and cold/flu/immunity (the Helpex brand family including Helpex Anticold NEO, Helpex LAR, Helpex Anticold DX, and Helpex Effect ointment, with Vitamin C + Zinc variants). The portfolio extends to Osteocitrate (calcium supplement) and Movespasm (antispasmodic), and the most recent launch, Novynka Moviryka, was introduced in November 2025.

The company's go-to-market relies on multi-channel distribution within Ukraine: sales through the national pharmacy network (including partner pharmacies participating in the Medicard discount program), direct supply arrangements with medical and pharmaceutical institutions handled via email at [email protected], and online pharmacy partnerships such as Apteka 911 for OTC products. The specialized internet publication at movi-health.com.ua serves as a content-marketing channel targeting physicians and pharmacists, featuring an extensive medical library of clinical research authored by Ukrainian medical university professors. The 'Freedom of Movement with MoviHealth' patient support program — operational from September 2017 through November 2026 in partnership with Medicard — provides discounts on Movex chondroprotectors and pain medications, addressing affordability for chronic joint patients.

Revenue mechanics are based on one-time unit sales of pharmaceuticals through pharmacy distribution; pricing is not publicly disclosed. Multiple Ukrainian regulatory registrations protect the formulations. The company has accumulated eight consecutive years of Panacea awards for its Movex product line (2018-2025) and Favorites of Success recognitions for Helpex, supported by independent research from MASMI, Quintiles IMS, SMD, Business Credit, Nielsen, and UMG. Ownership is private with no disclosed parent, external investors, or institutional shareholders. Geographic footprint is limited to Ukraine, with the registered operating region listed as Europe. Headcount is between 101 and 250 employees.

Name

Movi Health

Legal name

ТОВ "Мові Хелс"

Website

https://movi-health.com.ua

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

101–250 employees

Short description

Movi Health (ТОВ "Мові Хелс") is a Ukrainian pharmaceutical company founded in 2008 that develops and markets prescription and over-the-counter medications for joint health, respiratory conditions, and cold/flu symptoms, distributing through pharmacy networks and patient support programs across Ukraine.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Cold, Flu & Cough Remedies (HLAIADAB)

akta.pro secondary industries

OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), Women’s Health (OTC Gynecologic) (HLAIADAJ)

Keywords

• Pharmaceutical manufacturing
• Joint health medications
• Respiratory medications
• Cold and flu treatments
• Prescription and OTC drugs

Headquarters

HQ city

Kyiv

HQ country

Ukraine

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Pharmaceutical Product Sales: Direct sales of prescription and OTC medications through pharmacy distribution networks in Ukraine, including joint health products, respiratory medications, and cold/flu treatments.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Movi Health is a Ukrainian pharmaceutical company that develops, produces, and markets prescription (Rx) and over-the-counter (OTC) medications focused on three therapeutic areas: joint and musculoskeletal health (chondroprotectors, NSAIDs including orodispersible meloxicam), respiratory diseases (cold, flu, allergic rhinitis, bronchitis, COPD), and related conditions. The company distributes its portfolio of branded products (Movex, Helpex, PulmoBREEZE/PulmoBRIZ, PulmoLOR, Movixicam, Osteocitrate, Movespasm, Movinaza, MoviFlex DEX, Moviryka) through Ukrainian pharmacy networks, online pharmacies, and direct sales to medical institutions.

Product overview

Movi Health (ТОВ 'Мові Хелс') is a Ukrainian pharmaceutical company offering a comprehensive portfolio of over-the-counter and prescription medications. The product portfolio includes: joint health medications (Movex Comfort, Movex Active chondroprotectors, Movixicam ODT orodispersible tablets), respiratory medications (PulmoBREEZE, PulmoLOR), cold and flu treatments (Helpex Anticold NEO, Helpex LAR, Helpex Anticold DX, Helpex Effect), bone health supplements (Osteocitrate, Osteocitrate MAX), antispasmodics (Movespasm), and nasal medications (Movinaza). The company has won multiple 'Panacea' awards including for Movex Active, Helpex Anticold NEO, and PulmoBREEZE. The company operates a patient support program 'Freedom of Movement with MoviHealth' offering discounts on joint medications.

Differentiator

Problem solved

Functional benefit

Brands

• Helpex: Cold and flu medication brand including Helpex Anticold NEO, Helpex Anticold NEO MAX, Helpex Anticold NEO Ginger, Helpex Anticold NEO for Children, Helpex Effekt (ointment)
• Movex
• PulmoBRIZ
• PulmoLOR
• Movinaza
• Movixicam
• Osteocitrate
• Movespasm

Products and services

• Movex Comfort (Мовекс Комфорт) Chondroprotector containing glucosamine sulfate and chondroitin sulfate combination for joint health, available in 60 or 120 tablet packaging, indicated for joint and spine disease treatment.
• Movex Active (Мовекс Актив) Chondroprotector combined with anti-inflammatory properties that reduces pain and inflammation in joints, improves mobility, stimulates cartilage tissue restoration, and slows disease progression.
• Movixicam ODT (Мовіксикам ОДТ) Orodispersible meloxicam tablet for knee osteoarthritis and spine osteoarthritis treatment, providing pain management with improved patient compliance through orally disintegrating tablet form.
• PulmoBREEZE (ПульмоБРІЗ) Respiratory medication for treatment of upper respiratory tract diseases, available in sachet and tablet forms. Awarded Panacea 2025 for high efficacy and significant contribution to seasonal respiratory disease treatment.
• PulmoLOR (ПульмоЛОР) Respiratory medication for treatment of throat and ENT diseases, available in tablet and suspension forms, including a pediatric formulation with loratadine/ambroxol combination for children aged 6-12.
• Helpex Anticold NEO (Хелпекс Антиколд НЕО) Anti-cold medication with antiviral action, including sachets for adults and children's formulations with raspberry flavor. Contains paracetamol 750mg and levocetirizine dihydrochloride; manufactured in Switzerland.
• Helpex LAR (Хелпекс ЛАР) Throat treatment solution for sore throat relief, addressing ENT symptoms as part of the Helpex cold-care line.
• Helpex Effect (Хелпекс Ефект) Topical ointment for cold and pain relief with natural ingredients, supplied in convenient tube format for external application.
• Helpex Anticold DX (Хелпекс Антиколд ДХ) Anti-cold medication in tablet form for convenient at-hand treatment of flu and cold symptoms.

Quantifiable outcome

• 8 consecutive years of Panacea award recognition (2018-2025) for various products including Movex Active and Helpex brands
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered minor and core.

• Apteka 911minorChannel Partner/ Reseller/ Distributor · 7 April 2021Partnership with Apteka 911 online pharmacy service for distribution of OTC products. Apteka 911 provides online pharmacy services allowing consumers to purchase Movi Health products including Helpex cold medications. The partnership was celebrated on Apteka 911's 8th anniversary in April 2021.
• MedicardcoreChannel Partner/ Reseller/ Distributor · 1 September 2017Partnership with Medicard for the 'Freedom of Movement with MoviHealth' patient support program. Medicard provides discount program management services for patients purchasing joint health medications. Patients can inquire about participating pharmacies and discounts via the Medicard hotline 0-800-21-21-31 or website www.medicard.com.ua. The program runs from September 1, 2017 to November 30, 2026.

Scale indicators1 record

Recent moves6 records

Expansion highlights3 records

Direct peers

• Arterium (PrJSC Arterium): Arterium is a major Ukrainian pharmaceutical corporation combining Kyivmedpreparat and Halychpharm, producing Rx and OTC products across respiratory, anti-inflammatory, and musculoskeletal categories. It competes head-on with Movi Health in Ukrainian pharmacy channels and prescription-driven therapeutic areas.
• Darnitsa (PrJSC Pharmaceutical Firm Darnitsa): Darnitsa is one of Ukraine's top-10 pharmaceutical manufacturers, producing a wide range of prescription and OTC medications including analgesics, anti-inflammatories, and respiratory products. Its domestic market position, channel relationships, and therapeutic overlap make it a direct peer to Movi Health.
• Farmak: Farmak is the largest Ukrainian pharmaceutical manufacturer, offering a broad portfolio of Rx and OTC products across cardiovascular, respiratory, and pain categories. It is the closest domestic direct competitor to Movi Health in scale, channel, and therapeutic focus within the Ukrainian market.
• Borshchahivskiy Chemical-Pharmaceutical Plant: Borshchahivskiy CPP is a Kyiv-based Ukrainian pharma manufacturer producing generics and branded Rx/OTC products for respiratory, pain, and infectious-disease categories. It competes with Movi Health across both prescription and OTC pharmacy distribution in Ukraine.

Broad incumbents

• Stada Arzneimittel: Stada is a major German generic and consumer healthcare company with broad Eastern European operations. Its generics and OTC portfolio in pain relief, cold/flu, and joint health overlaps with Movi Health's product range, though Stada operates at significantly greater scale across many markets.
• Teva Pharmaceutical Industries: Teva is the world's largest generic pharmaceutical manufacturer with operations in Ukraine and globally, producing prescription and OTC medications including NSAIDs, respiratory, and musculoskeletal products. It competes with Movi Health in overlapping molecule categories across the Ukrainian market.
• Sandoz (Novartis): Sandoz is a global leader in generics and biosimilars with a substantial European footprint including Eastern Europe. Its portfolio includes OTC analgesics, respiratory, and musculoskeletal generics that overlap with Movi Health's offerings in the broader regional market.

Regional players

• Acino: Acino is a Swiss-headquartered pharmaceutical company focused on emerging markets including Ukraine and CIS countries, producing branded generics and OTC products across multiple therapeutic categories. Its Ukraine focus and product mix in pain, respiratory, and musculoskeletal make it a relevant regional peer.
• KRKA: KRKA is a Slovenian generic pharmaceutical manufacturer with a deep Central and Eastern European footprint including Ukraine, producing prescription and OTC products across pain, respiratory, and cardiovascular categories. Comparable to Movi Health in therapeutic focus but materially larger and more geographically diversified.
• Zentiva: Zentiva is a European generics pharmaceutical company headquartered in Prague with strong Central and Eastern European operations including Ukraine. It produces prescription and OTC medications in overlapping categories (pain, inflammation, respiratory), competing with Movi Health's product portfolio in the Ukrainian market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Movi Health